Venture capital funding of life science companies was down during the first quarter of 2013, in both volume deals and dollars invested. Venture capital funds invested $1.4 billion in 167 industry deals in first quarter, a drop of 14 percent in dollars and 16 percent in the number of deals when compared to the same quarter last year, according to a new PwC US report, “Capital Crunch,” that includes data from the PricewaterhouseCoopers LLP/National Venture Capital Association MoneyTree Report, based on data from Thomson Reuters.
To read the original article: Venture capital investment in life science drops 14 percent in Q1 - St. Louis Business Journal
